Hepatitis C virus-mediated modulation of cellular immunity

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 5, 2012, Pages 315-329

  Brenndörfer, Erwin Daniel ^a   Sällberg, Matti ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adaptive immune response; Dendritic cells; HCV; Kupffer cells; NK cells; NKT cells

Indexed keywords

DNA VACCINE; HEPATITIS C VACCINE; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 5A; PEGINTERFERON ALPHA; RIBAVIRIN;

ACUTE HEPATITIS; ADAPTIVE IMMUNITY; ANTIVIRAL ACTIVITY; APOPTOSIS; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; CHEMOTAXIS; CHRONIC HEPATITIS; CYTOKINE RESPONSE; DNA IMMUNIZATION; DRUG EFFICACY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFECTION PREVENTION; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MYELOID DENDRITIC CELL; NATURAL KILLER CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PLASMACYTOID DENDRITIC CELL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INDUCTION; VIRUS INTERFERENCE;

ANIMALS; DENDRITIC CELLS; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; IMMUNITY, INNATE; IMMUNOTHERAPY; INFLAMMATION; KILLER CELLS, NATURAL; LIVER; LIVER CIRRHOSIS; MODELS, BIOLOGICAL;

EID: 84866599314     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0184-z     Document Type: Review

References (179)

1. Abel M, Sene D, Pol S et al (2006) Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology 44:1607-1616 (Pubitemid 44953666)
2. Ahlenstiel G, Martin MP, Gao X et al (2008) Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 118:1017-1026 (Pubitemid 351364609)
3. Ahlenstiel G, Titerence RH, Koh C et al (2010) Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa- dependent manner. Gastroenterology 138(325-335):e1-e2
4. Alatrakchi N, Graham CS, van der Vliet HJ et al (2007) Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol 81:5882-5892 (Pubitemid 46847025)
5. Amadei B, Urbani S, Cazaly A et al (2010) Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology 138:1536-1545
6. Andoniou CE, Andrews DM, Degli-Esposti MA (2006) Natural killer cells in viral infection: more than just killers. Immunol Rev 214:239-250 (Pubitemid 44707915)
7. Appay V, Dunbar PR, Callan M et al (2002) Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8:379-385 (Pubitemid 34407033)
8. Auffermann-Gretzinger S, Keeffe EB, Levy S (2001) Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97:3171-3176
9. Averill L, Lee WM, Karandikar NJ (2007) Differential dysfunction in dendritic cell subsets during chronic HCV infection. Clin Immunol 123:40-49 (Pubitemid 46401508)
10. Bain C, Fatmi A, Zoulim F et al (2001) Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120:512-524 (Pubitemid 32147649)
11. Barnes E, Folgori A, Capone S et al (2012) Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. Sci Transl Med 4(115):115ra1
12. Bartosch B, Bukh J, Meunier JC et al (2003) In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci USA 100:14199-14204 (Pubitemid 37499214)
13. Bassett SE, Guerra B, Brasky K et al (2001) Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 33:1479-1487 (Pubitemid 32496985)
14. Bataller R, Paik YH, Lindquist JN et al (2004) Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology 126:529-540 (Pubitemid 38182310)
15. Bengsch B, Seigel B, Ruhl M et al (2010) Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 6:e1000947
16. Blackard JT, Kang M, Sherman KE et al (2006) Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. J Interferon Cytokine Res 26:834-838 (Pubitemid 44764546)
17. Bode JG, Brenndorfer ED, Haussinger D (2008) Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response. Biol Chem 389:1283-1298
18. Bode JG, Brenndorfer ED, Karthe J et al (2009) Interplay between host cell and hepatitis C virus in regulating viral replication. Biol Chem 390:1013-1032
19. Boettler T, Spangenberg HC, Neumann-Haefelin C et al (2005) T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79:7860-7867 (Pubitemid 40756821)
20. Brady MT, MacDonald AJ, Rowan AG et al (2003) Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 33:3448-3457 (Pubitemid 37541123)
21. Brenndorfer ED, Karthe J, Frelin L et al (2009) Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factorinduced signal transduction by cleavage of the T-cell protein tyrosine phosphatase. Hepatology 49:1810-1820
22. Brenndorfer ED, Weiland M, Frelin L et al (2010) Anti-tumor necrosis factor alpha treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C. Hepatology 52:1553-1563
23. Brenndorfer ED, Brass A, Soderholm J et al (2012) Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-gamma production. Gut 61:589-596
24. Brooks DG, Trifilo MJ, Edelmann KH et al (2006) Interleukin-10determines viral clearance or persistence in vivo. Nat Med 12:1301-1309 (Pubitemid 44706933)
25. Burgio VL, Ballardini G, Artini M et al (1998) Expression of costimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology 27:1600-1606 (Pubitemid 28264685)
26. Cabrera R, Tu Z, Xu Y et al (2004) An immunomodulatory role for CD4 (+) CD25 (+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40:1062-1071 (Pubitemid 39425561)
27. Cacciarelli TV, Martinez OM, Gish RG et al (1996) Immunoregulatory cytokines in chronic hepatitis C virus infection: pre-and posttreatment with interferon alfa. Hepatology 24:6-9 (Pubitemid 26249404)
28. Chang KM, Rehermann B, McHutchison JG et al (1997) Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clinical Invest 100:2376-2385 (Pubitemid 27500163)
29. Chen CH, Kuo LM, Chang Y et al (2006) In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 44:1171-1181 (Pubitemid 44748368)
30. Chen A, Ahlen G, Brenndorfer ED et al (2011) Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination. J Immunol 186:5107-5118
31. Cooper S, Erickson AL, Adams EJ et al (1999) Analysis of a successful immune response against hepatitis C virus. Immunity 10:439-449 (Pubitemid 29205480)
32. Corado J, Toro F, Rivera H et al (1997) Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin Exp Immunol 109:451-457 (Pubitemid 27402312)
33. Cox AL, Mosbruger T, Lauer GM et al (2005) Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 42:104-112 (Pubitemid 40911317)
34. Crotta S, Stilla A, Wack A et al (2002) Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 195:35-41 (Pubitemid 34074494)
35. Crotta S, Brazzoli M, Piccioli D et al (2010) Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection. J Hepatol 52:183-190
36. Curry MP, Golden-Mason L, Doherty DG et al (2003) Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J Hepatol 38:642-650 (Pubitemid 36560650)
37. Day CL, Lauer GM, Robbins GK et al (2002) Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 76:12584-12595 (Pubitemid 35386944)
38. Day CL, Seth NP, Lucas M et al (2003) Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest 112:831-842 (Pubitemid 38063741)
39. de Lalla C, Galli G, Aldrighetti L et al (2004) Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol 173:1417-1425 (Pubitemid 38924323)
40. De Maria A, Fogli M, Mazza S et al (2007) Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol 37:445-455 (Pubitemid 46915584)
41. De Re V, Sansonno D, Simula MP et al (2006) HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia 20:1145-1154 (Pubitemid 43797310)
42. de Re V, Caggiari L, Simula MP et al (2007) B-cell lymphomas associated with HCV infection. Gastroenterology 132:1205-1207 (Pubitemid 46440896)
43. Deignan T, Curry MP, Doherty DG et al (2002) Decrease in hepatic CD56 (+) T cells and V alpha 24 (+) natural killer T cells in chronic hepatitis C viral infection. J Hepatol 37:101-108 (Pubitemid 34713061)
44. Della Bella S, Crosignani A, Riva A et al (2007) Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection. Immunology 121:283-292 (Pubitemid 46663097)
45. Dolganiuc A, Kodys K, Kopasz A et al (2003) Hepatitis C virus core and nonstructural protein 3 proteins induce pro-and antiinflammatory cytokines and inhibit dendritic cell differentiation. J Immunol 170:5615-5624 (Pubitemid 36617852)
46. Dolganiuc A, Oak S, Kodys K et al (2004) Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127:1513-1524 (Pubitemid 39457776)
47. Dolganiuc A, Chang S, Kodys K et al (2006) Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol 177:6758-6768 (Pubitemid 44715040)
48. Dolganiuc A, Norkina O, Kodys K et al (2007) Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 133:1627-1636 (Pubitemid 350029734)
49. Dolganiuc A, Paek E, Kodys K et al (2008) Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes. Gastroenterology 135:2119-2127
50. Dorner T, Radbruch A (2007) Antibodies and B cell memory in viral immunity. Immunity 27:384-392 (Pubitemid 47418684)
51. Echeverria I, Pereboev A, Silva L et al (2011) Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells. Hepatology 54:28-37
52. Ejrnaes M, Filippi CM, Martinic MM et al (2006) Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 203:2461-2472 (Pubitemid 44664616)
53. Erickson AL, Kimura Y, Igarashi S et al (2001) The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15:883-895 (Pubitemid 34075370)
54. Farci P, Shimoda A, Coiana A et al (2000) The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339-344 (Pubitemid 30226196)
55. Firbas C, Boehm T, Buerger V et al (2010) Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine. Vaccine 28:2397-2407
56. Frasca L, Del Porto P, Tuosto L et al (1999) Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells. J Immunol 163:650-658 (Pubitemid 29328069)
57. Frelin L, Brenndorfer ED, Ahlen G et al (2006) The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease. Gut 55:1475-1483 (Pubitemid 44476794)
58. Frey SE, Houghton M, Coates S et al (2010) Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59administered to healthy adults. Vaccine 28:6367-6373
59. Geissmann F, Cameron TO, Sidobre S et al (2005) Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 3:e113
60. Gerlach JT, Diepolder HM, Zachoval R et al (2003) Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125:80-88 (Pubitemid 36799109)
61. Gill HS, Soderholm J, Prausnitz MR, Sallberg M (2010) Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther 17:811-814
62. Golden-Mason L, Palmer B, Klarquist J et al (2007) Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 81:9249-9258 (Pubitemid 47311467)
63. Golden-Mason L, Klarquist J, Wahed AS et al (2008a) Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences. J Immunol 180:3637-3641
64. Golden-Mason L, Madrigal-Estebas L, McGrath E et al (2008b) Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 57:1121-1128
65. Golden-Mason L, Palmer BE, Kassam N et al (2009) Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 83:9122-9130
66. Gowans EJ, Roberts S, Jones K et al (2010) A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals. J Hepatol 53:599-607
67. Grakoui A, Shoukry NH, Woollard DJ et al (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302:659-662 (Pubitemid 37310924)
68. Gruener NH, Lechner F, Jung MC et al (2001) Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 75:5550-5558 (Pubitemid 32488148)
69. Habersetzer F, Honnet G, Bain C et al (2011) A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C. Gastroenterology 141:890-899
70. He XS, Rehermann B, Lopez-Labrador FX et al (1999) Quantitative analysis of hepatitis C virus-specific CD8 (+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 96:5692-5697 (Pubitemid 29234680)
71. Herzer K, Falk CS, Encke J et al (2003) Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J Virol 77:8299-8309 (Pubitemid 36871458)
72. Holz LE, Benseler V, Bowen DG et al (2008) Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology 135:989-997
73. Huang L, Soldevila G, Leeker M et al (1994) The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1:741-749
74. Hultgren C, Milich DR, Weiland O et al (1998) The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 79(Pt 10):2381-2391 (Pubitemid 28464295)
75. Iwai Y, Terawaki S, Ikegawa M et al (2003) PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 198:39-50 (Pubitemid 36870184)
76. Jinushi M, Takehara T, Tatsumi T et al (2004) Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J Immunol 173:6072-6081 (Pubitemid 39487763)
77. Kalams SA, Walker BD (1998) The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 188:2199-2204 (Pubitemid 29028492)
78. Kanto T, Hayashi N, Takehara T et al (1999) Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162:5584-5591 (Pubitemid 29307172)
79. Kanto T, Inoue M, Miyatake H et al (2004) Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 190:1919-1926 (Pubitemid 39564696)
80. Kanto T, Inoue M, Miyazaki M et al (2006) Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels. Intervirology 49:58-63 (Pubitemid 41318177)
81. Kaplan DE, Ikeda F, Li Y et al (2008) Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis. J Hepatol 48:903-913
82. Kawarabayashi N, Seki S, Hatsuse K et al (2000) Decrease of CD56 (+) T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 32:962-969
83. Khakoo SI, Thio CL, Martin MP et al (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305:872-874 (Pubitemid 39038423)
84. Kimura T, Saito T, Yoshimura M et al (2006) Association of transforming growth factor-beta 1 functional polymorphisms with natural clearance of hepatitis C virus. J Infect Dis 193:1371-1374 (Pubitemid 43673384)
85. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ et al (2000) Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 106:1239-1249
86. Klade CS, Wedemeyer H, Berg T et al (2008) Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41. Gastroenterology 134:1385-1395
87. Knapp S, Hennig BJ, Frodsham AJ et al (2003) Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 55:362-369 (Pubitemid 37255487)
88. Knapp S, Warshow U, Hegazy D et al (2010) Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology 51:1168-1175
89. Kriegs M, Burckstummer T, Himmelsbach K et al (2009) The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo. J Biol Chem 284:28343-28351
90. Lanford RE, Guerra B, Chavez D et al (2004) Cross-genotype immunity to hepatitis C virus. J Virol 78:1575-1581 (Pubitemid 38095866)
91. Langhans B, Kupfer B, Braunschweiger I et al (2011) Interferonlambda serum levels in hepatitis C. J Hepatol 54:859-865
92. Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345:41-52 (Pubitemid 32634271)
93. Lazdina U, Hultgren C, Frelin L et al (2001) Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein. J Gen Virol 82 (Pt 6):1299-1308 (Pubitemid 32519759)
94. Lechner F, Wong DK, Dunbar PR et al (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499-1512 (Pubitemid 30257347)
95. Li K, Foy E, Ferreon JC et al (2005a) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 102:2992-2997 (Pubitemid 40299904)
96. Li XD, Sun L, Seth RB, Pineda G et al (2005b) Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci USA 102:17717-17722 (Pubitemid 41803563)
97. Liang TJ, Rehermann B, Seeff LB et al (2000) Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132:296-305 (Pubitemid 30106261)
98. Liang H, Russell RS, Yonkers NL et al (2009) Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells. J Virol 83:5693-5707
99. Lichterfeld M, Leifeld L, Nischalke HD et al (2002) Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection. J Infect Dis 185:1803-1807 (Pubitemid 34615477)
100. Lin AW, Gonzalez SA, Cunningham-Rundles S et al (2004) CD56 (+dim) and CD56 (+bright) cell activation and apoptosis in hepatitis C virus infection. Clin Exp Immunol 137:408-416 (Pubitemid 39013089)
101. Lin W, Tsai WL, Shao RX et al (2010) Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaBdependent manner. Gastroenterology 138:2509-2518 2518.e1
102. Logvinoff C, Major ME, Oldach D et al (2004) Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci USA 101:10149-10154 (Pubitemid 38891210)
103. Maher SG, Romero-Weaver AL, Scarzello AJ et al (2007) Interferon: cellular executioner or white knight? Curr Med Chem 14:1279-1289 (Pubitemid 46746361)
104. Marie JC, Letterio JJ, Gavin M et al (2005) TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201:1061-1067 (Pubitemid 40524674)
105. Marukian S, Jones CT, Andrus L et al (2008) Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48:1843-1850
106. Matloubian M, Concepcion RJ, Ahmed R (1994) CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68:8056-8063 (Pubitemid 24362694)
107. Mayo MJ (2003) Extrahepatic manifestations of hepatitis C infection. Am J Med Sci 325:135-148 (Pubitemid 36348619)
108. Meier UC, Owen RE, Taylor E et al (2005) Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J Virol 79:12365-12374 (Pubitemid 41346098)
109. Mengshol JA, Golden-Mason L, Castelblanco N et al (2009) Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes. Gut 58:964-973
110. Mengshol JA, Golden-Mason L, Arikawa T et al (2010) A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS ONE 5:e9504
111. Meylan E, Curran J, Hofmann K et al (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172 (Pubitemid 41509355)
112. Morishima C, Paschal DM, Wang CC et al (2006) Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 43:573-580
113. Muhlbauer M, Fleck M, Schutz C et al (2006) PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J Hepatol 45:520-528 (Pubitemid 44307379)
114. Murakami H, Akbar SM, Matsui H et al (2004) Decreased interferonalpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin Exp Immunol 137:559-565 (Pubitemid 39128083)
115. Nakamoto N, Kaplan DE, Coleclough J et al (2008) Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 134:1927-1937 1937.e1-e2
116. Nakamoto N, Cho H, Shaked A et al (2009) Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 5:e1000313
117. Nattermann J, Nischalke HD, Hofmeister V et al (2005) The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am J Pathol 166:443-453 (Pubitemid 40189041)
118. Nattermann J, Feldmann G, Ahlenstiel G et al (2006) Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55:869-877 (Pubitemid 43764560)
119. Neumann AU, Lam NP, Dahari H et al (1998) Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282:103-107 (Pubitemid 28471138)
120. Ning Q, Brown D, Parodo J et al (1998) Ribavirin inhibits viralinduced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 160:3487-3493 (Pubitemid 28164743)
121. Norris S, Doherty DG, Collins C et al (1999) Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells. Hum Immunol 60:20-31 (Pubitemid 29057853)
122. Nuti S, Rosa D, Valiante NM et al (1998) Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 28:3448-3455 (Pubitemid 28510755)
123. Nystrom J, Chen A, Frelin L et al (2010) Improving on the ability of endogenous hepatitis B core antigen to prime cytotoxic T lymphocytes. J Infect Dis 201:1867-1879
124. Oliviero B, Varchetta S, Paudice E et al (2009) Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137:1151-1160 1160.e1-e7
125. Pal S, Sullivan DG, Kim S et al (2006) Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 130:1107-1116
126. Paladino N, Fainboim H, Theiler G et al (2006) Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. J Virol 80:9144-9150 (Pubitemid 44359986)
127. Parren PW, Burton DR (2001) The antiviral activity of antibodies in vitro and in vivo. Adv Immunol 77:195-262 (Pubitemid 33703707)
128. Pasetto A, Frelin L, Brass A et al (2012) Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus nonstructural protein 3. J Gen Virol 93(Pt 2):247-258
129. Pelletier S, Drouin C, Bedard N et al (2010) Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses. J Hepatol 53:805-816
130. Penna A, Pilli M, Zerbini A et al (2007) Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 45:588-601 (Pubitemid 46450610)
131. Perrella A, Atripaldi L, Bellopede P et al (2006a) Flow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms. World J Gastroenterol 12:1105-1109
132. Perrella A, Vitiello L, Atripaldi L et al (2006b) Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution. Gut 55:1370-1371 (Pubitemid 44277380)
133. Persico M, Capasso M, Persico E et al (2006) Interleukin-10-1082GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. J Hepatol 45:779-785 (Pubitemid 44646685)
134. Piazzolla G, Tortorella C, Schiraldi O, Antonaci S (2000) Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha. J Clin Immunol 20:54-61 (Pubitemid 30210107)
135. Poynard T, Yuen MF, Ratziu V et al (2003) Viral hepatitis C. Lancet 362:2095-2100 (Pubitemid 38035201)
136. Radkowski M, Gallegos-Orozco JF, Jablonska J et al (2005) Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41:106-114 (Pubitemid 40066388)
137. Radziewicz H, Ibegbu CC, Fernandez ML et al (2007) Liverinfiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 81:2545-2553 (Pubitemid 46447020)
138. Rehermann B (2009) Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 119:1745-1754
139. Reiser M, Marousis CG, Nelson DR et al (1997) Serum interleukin 4and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol 26:471-478 (Pubitemid 27112709)
140. Riezu-Boj JI, Larrea E, Aldabe R et al (2011) Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection. J Hepatol 54:422-431
141. Rigopoulou EI, Abbott WG, Haigh P et al (2005) Blocking of interleukin-10 receptor-a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin Immunol 117:57-64 (Pubitemid 41725470)
142. Rushbrook SM, Ward SM, Unitt E et al (2005) Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 79:7852-7859 (Pubitemid 40756820)
143. Sallberg M, Frelin L, Diepolder H et al (2009) A first clinical trial of therapeutic vaccination using naked DNA delivered by in vivo electroporation shows antiviral effects in patients with chronic hepatitis C. J Hepatol 50:S18-S19
144. Schlaphoff V, Lunemann S, Suneetha PV et al (2011) Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCVspecific CD8+ T cells. PLoS Pathog 7:e1002045
145. Schulte D, Vogel M, Langhans B et al (2009) The HLA-E (R)/HLAE (R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gammasecreting human CD8 (+) T cells. J Infect Dis 200:1397-1401
146. Seifert U, Liermann H, Racanelli V et al (2004) Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest 114:250-259 (Pubitemid 39071630)
147. Semmo N, Day CL, Ward SM et al (2005) Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 41:1019-1028 (Pubitemid 40593910)
148. Shen T, Chen X, Chen Y et al (2010) Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection. J Med Virol 82:1152-1159
149. Shimizu YK, Hijikata M, Iwamoto A et al (1994) Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 68:1494-1500 (Pubitemid 24065713)
150. Shin EC, Seifert U, Kato T et al (2006) Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J Clin Invest 116:3006-3014 (Pubitemid 44684485)
151. Sugimoto K, Ikeda F, Stadanlick J et al (2003) Suppression of HCVspecific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38:1437-1448 (Pubitemid 37466970)
152. Takahashi K, Asabe S, Wieland S et al (2010) Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci USA 107:7431-7436
153. Taniguchi M, Harada M, Kojo S et al (2003) The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 21:483-513 (Pubitemid 37174539)
154. Thimme R, Oldach D, Chang KM et al (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194:1395-1406 (Pubitemid 33081515)
155. Thomas E, Feld JJ, Li Q et al (2011) Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models. Hepatology 53:32-41
156. Timm J, Lauer GM, Kavanagh DG et al (2004) CD8 epitope escape and reversion in acute HCV infection. J Exp Med 200:1593-1604 (Pubitemid 40094183)
157. Tsai SL, Liaw YF, Chen MH et al (1997) Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25:449-458
158. Tsai SL, Chen YM, Chen MH et al (1998) Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. Gastroenterology 115:954-965
159. Tseng CT, Klimpel GR (2002) Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 195:43-49 (Pubitemid 34074495)
160. Uebelhoer L, Han JH, Callendret B et al (2008) Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness. PLoS Pathog 4:e1000143
161. Ulsenheimer A, Gerlach JT, Gruener NH et al (2003) Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 37:1189-1198 (Pubitemid 36538697)
162. Urbani S, Amadei B, Fisicaro P et al (2006a) Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 44:126-139 (Pubitemid 44049146)
163. Urbani S, Amadei B, Tola D et al (2006b) PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCVspecific CD8 exhaustion. J Virol 80:11398-11403 (Pubitemid 44706581)
164. Vidal-Castineira JR, Lopez-Vazquez A, Diaz-Pena R et al (2010) Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J Virol 84:475-481
165. Wedemeyer H, He XS, Nascimbeni M et al (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169:3447-3458 (Pubitemid 35013196)
166. Weiner AJ, Paliard X, Selby MJ et al (2001) Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity. J Virol 75:7142-7148 (Pubitemid 32641602)
167. Wertheimer AM, Bakke A, Rosen HR (2004) Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 40:335-345 (Pubitemid 39062851)
168. Woitas RP, Ahlenstiel G, Iwan A et al (2002) Frequency of the HIVprotective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. Gastroenterology 122:1721-1728 (Pubitemid 34651414)
169. Woollard DJ, Grakoui A, Shoukry NH et al (2003) Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee. Hepatology 38:1297-1306 (Pubitemid 37314840)
170. Yamagiwa S, Gray JD, Hashimoto S et al (2001) A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 166:7282-7289 (Pubitemid 32525603)
171. Yamagiwa S, Matsuda Y, Ichida T et al (2008) Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells. Hepatol Res 38:664-672 (Pubitemid 351784979)
172. Yao ZQ, Nguyen DT, Hiotellis AI et al (2001) Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J Immunol 167:5264-5272 (Pubitemid 33009764)
173. Yao ZQ, Eisen-Vandervelde A, Waggoner SN et al (2004) Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt. J Virol 78:6409-6419 (Pubitemid 38715939)
174. Yoon JC, Shiina M, Ahlenstiel G et al (2009) Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology 49:12-21
175. Zeremski M, Petrovic LM, Talal AH (2007) The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat 14:675-687 (Pubitemid 47414927)
176. Zhang Y, Liu Y, Moxley KM et al (2010) Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity. PLoS Pathog 6:e1001018
177. Zhang Y, Ma CJ, Ni L et al (2011a) Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection. J Immunol 186:3093-3103
178. Zhang Y, Ma CJ, Wang JM et al (2011b) Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection. PLoS ONE 6:e19664
179. Zimmermann M, Flechsig C, La Monica N et al (2008) Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes. J Hepatol 48:51-60 (Pubitemid 350191988)